Form 4: Encompass Health Director Acquires Additional Shares Through Deferred Stock Plan

Director Edward M. Christie III acquired 268 shares of Encompass Health Corp through the company's deferred stock investment plan at a weighted average price of $102.56 on April 24, 2025.

Summary

• On April 24, 2025, Edward M. Christie III, a director of Encompass Health Corp, acquired 268 shares of Encompass Health common stock.
• The acquisition was made through the company's Directors Deferred Stock Investment Plan.
• The shares were purchased at a weighted average price of $102.56, with individual prices ranging from $102.48 to $102.56.
• Following the transaction, Christie's direct ownership in Encompass Health common stock increased to 4,982 shares.
• The Directors Deferred Stock Investment Plan allows non-employee directors to defer a percentage of their director fees, which are then used to purchase company stock.
• Dividends received on these shares are reinvested in Encompass Health common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's participation in the deferred stock plan indicates confidence in the company, but it's a routine transaction.

Positives

• Director's participation in the deferred stock plan signals confidence in the company's future.
• The reinvestment of dividends further increases the director's stake in the company.

Industry Context

This transaction reflects a common practice among publicly traded companies to offer deferred stock plans to directors, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Deferred stock plans are a typical component of director compensation packages in publicly traded companies, such as HCA Healthcare (HCA) and Universal Health Services (UHS).
• The level of director stock ownership is generally viewed positively by investors, as it aligns management's interests with those of shareholders, similar to practices observed at Tenet Healthcare (THC).

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with theirs.
• The transaction has no material impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Encompass Health, Director, Stock Acquisition, Deferred Stock Plan, EHC, Beneficial Ownership, Form 4